Results 91 to 100 of about 226,399 (222)

Rare presentation of intrathecal morphine withdrawal psychosis

open access: yes, 2017
We report a case of a 57-year-old male patient with intrathecal morphine pump failure who presented with psychosis as part of a clinical presentation of opioid withdrawal.
Rohit Aiyer   +4 more
core   +1 more source

Effects of antidepressants on morphine withdrawal

open access: yes, 1998
The acute and chronic effects of paroxetine and fluoxetine on naloxone- withdrawal-induced place aversion in morphine dependent rats were investigated.
Rafieian-Kopaei, M.
core   +1 more source

Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada

open access: yesThe American Journal on Addictions, Volume 35, Issue 5, Page 615-621, September 2026.
Abstract Background and Objectives Readmission to residential treatment increases healthcare costs, strains publicly funded systems, and may not adequately meet clients' needs. This study examined rates and predictors of readmission to residential treatment among clients transitioned from detoxification services.
Abreham Mekonnen
wiley   +1 more source

Depressive-like behaviors develop during the morphine withdrawal period.

open access: yes, 2013
(A) Locomotor activity was not influenced by the previous morphine exposure after 1 or 4 weeks of withdrawal. (B) The morphine treated mice spent less time in the center of the arena after 4 weeks of withdrawal.
Ying Du (42066)   +8 more
core   +1 more source

Effect of Rosmarinus officinalis L. Aerial Parts Extract and Fractions on Morphine Withdrawal Syndrome in Mice

open access: yesJournal of Medicinal Plants, 2006
Background: Our previous studies have shown that the aqueous and ethanolic extracts of Rosmarinus officinalis L. aerial parts reduce morphine withdrawal syndrome in mice. Objective: As R. officinalis L.
H Hosseinzadeh   +2 more
doaj  

Extended‐release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18‐month retrospective case series

open access: yesThe American Journal on Addictions, Volume 35, Issue 5, Page 638-642, September 2026.
Abstract Background and Objectives Poppy seed tea (PST) contains unpredictable opioid concentrations, destabilising tolerance and increasing overdose risk. Extended‐release buprenorphine (BUP‐XR) provides sustained coverage without daily dosing. Methods Eighteen‐month follow‐up of adults (N = 3) with opioid use disorder (OUD) involving PST in Australia.
John McMaster   +4 more
wiley   +1 more source

Mapping of a quantitative trait locus for morphine withdrawal severity.

open access: yes, 2004
Chronic morphine exposure results in physical dependence, manifested by physical symptoms during naloxone-precipitated withdrawal. Jumping frequency is widely considered the most sensitive and reliable index of withdrawal intensity in mice.
Mogil, J S   +4 more
core   +1 more source

Impact of Withdrawal of Extended‐Release Morphine 5 mg on Hospital Analgesic Utilization

open access: yes
Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 4, October 2026.
Mille Vraa Gamborg Eisenhardt   +4 more
wiley   +1 more source

When Urgency Drops: Temporal Consciousness and the Choreography of Dying

open access: yesAnthropology of Consciousness, Volume 37, Issue 2, Fall 2026.
ABSTRACT In the hospital, the transition from fighting for life to preparing for death involves not only a shift in medical repertoires but also a profound transformation in temporal experience. Drawing on ethnographic fieldwork in a Canadian intensive care unit, this article examines how the tempo of care, its rhythms, urgencies, and pauses shapes ...
Louise Chartrand
wiley   +1 more source

Technology‐Driven Decision Support for Opioid Tapering: A Scoping Review

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 3, September 2026.
ABSTRACT Background General practitioners manage most opioid tapering. This process requires time‐consuming, individualised planning accounting for patient preferences, dose options and costs. Consequently, clinicians need tools to support tapering.
Laurits Valberg Hemmingsen   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy